Pharmaceutical & Biotech
Takeda Completes $62 Billion Shire Acquisition, an Industrial Info Market Brief
Takeda's $62 billion purchase of Shire Plc is now complete.
Released Thursday, January 10, 2019
Reports related to this article:
In what is described as the largest foreign takeover by a Japanese company, drug maker Takeda's $62 billion purchase of Shire Plc is now complete. The two companies generate a combined $30 billion annual revenue. Under the deal, Takeda acquired Shire's recently-opened $1 billion immunoglobulin plasma fractionation plant in Covington, Georgia. The company is the site's fourth owner, having changed hands three other times since construction began in 2013.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Life-Science New Build Report: 200 North American Sites in P...November 04, 2014
-
Pharma-Biotech Industry Capital Investment Tops $12 Billion ...January 14, 2014
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
Latin America Data Center Outlook 2026: Power, Hubs & GrowthPodcast Episode / Oct 9, 2026
-
Food and Beverage CapEx Outlook 2026: Tariffs, AI, AfricaPodcast Episode / Oct 9, 2026
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1, CDMO and ReshoringPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026